← Back to Search

Nest Platform for Genetic Cancer Risk Management

N/A

Recruiting

Led By Jennifer Mack, MD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at post-visit survey, up to 30 days

Awards & highlights

Study Summary

This trial is developing an electronic platform to help young cancer patients access up-to-date info to better understand genetic testing results.

Who is the study for?

This trial is for young adults aged 18-39 who have had cancer genetic testing and know their results, which include pathogenic variants or VUS. Participants must speak English, not be undergoing active cancer therapy, and receive care at Dana-Farber Cancer Institute. Eligible healthcare providers include oncologists, nurse practitioners, physician assistants, and genetic counselors caring for this age group.Check my eligibility

What is being tested?

The trial is developing an electronic platform called Nest that provides updated information on genetic risks to patients and clinicians. It's designed for those who've undergone genetic testing for cancer susceptibility to better manage their health information.See study design

What are the potential side effects?

Since the intervention involves using an electronic platform (Nest portal) rather than a medical treatment or drug, traditional physical side effects are not applicable. However, there may be potential issues related to data privacy or emotional impact from accessing such information.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at post-visit survey, up to 30 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at post-visit survey, up to 30 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and at post-visit survey, up to 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of Clinician Utilization (Feasibility)

Proportion of Clinicians with AIM Score > 4

Proportion of Clinicians with FIM (Feasibility of Intervention Measure) Score > 4

+2 more

Secondary outcome measures

Change in Recommended screening

Change in knowledge of cancer risk

Trial Design

2Treatment groups

Experimental Treatment

Group I: Nest Refinement PhaseExperimental Treatment1 Intervention

20 participants and clinicians will complete study procedures as outlined: Nest portal orientation and access. Semi-structured, 30-minute interviews. Solicited feedback on content and processes will refine the intervention for a pilot phase.

Group II: Nest Pilot PhaseExperimental Treatment1 Intervention

10 Participants and 10 clinicians will complete study procedures as outlined: Baseline survey (participant). Standard clinic visit. Nest portal orientation and access (participant and clinician). Post-visit survey (participant and clinician). Brief, 30-minute, semi-structured interview (participant and clinician).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,937 Total Patients Enrolled

Nest GenomicsUNKNOWN

Jennifer Mack, MDPrincipal InvestigatorDana-Farber Cancer Institute

1 Previous Clinical Trials

354 Total Patients Enrolled

Media Library

Nest Refinement Phase Clinical Trial Eligibility Overview. Trial Name: NCT05759143 — N/A

Genetic Predisposition Research Study Groups: Nest Refinement Phase, Nest Pilot Phase

Genetic Predisposition Clinical Trial 2023: Nest Refinement Phase Highlights & Side Effects. Trial Name: NCT05759143 — N/A

Nest Refinement Phase 2023 Treatment Timeline for Medical Study. Trial Name: NCT05759143 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research involve volunteers aged sixty and above?

"To qualify for this trial, participants must be aged between 18 and 39. Additionally, there are 12 trials that accept subjects below the age of majority and 33 for seniors over 65 years old."

Answered by AI

What prerequisites must be fulfilled in order to participate in this trial?

"Eligibility criteria for this study dictates that the participants need to have a genetic predilection and be between 18-39 years old. The current recruitment process is seeking approximately 40 patients in total."

Answered by AI

Does this clinical experiment currently have any spots available for participants?

"Evidence on clinicaltrials.gov reveals that, even though this particular medical trial was first posted in August of 2023 and updated as recently as March 6th, it is currently not enrolling participants. Nevertheless, there are still 39 other studies actively looking for volunteers at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing

Jennifer Mack, MD 2023. "Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05759143.